top of page

We are Winning: 2026 Updates

1 hour ago
5 min read

Those are three words I don't take lightly. The past 12 months have been some of the most challenging, exhausting, and rewarding of our lives. There have been long days, sleepless nights, difficult decisions, and moments when the weight of Duchenne Muscular Dystrophy feels overwhelming. But there has also been extraordinary progress.


When Lauren and I started Decker's Blueprint, we had one mission: to fight for Decker and the thousands of boys with Duchenne who are being left behind by today's treatments. Our goal is to help turn this devastating disease into a chronic, manageable condition so these boys can grow up, pursue their dreams, build families, and live full lives.


Today, thanks to all of you, we are making meaningful progress toward that future.

 

OVER $900,000 RAISED. REAL SCIENCE. REAL PROGRESS.

In just 12 months of active fundraising, Decker's Blueprint has raised more than $900,000 toward our goal of $5 million by December 31, 2028.


We are proud that our Board of Directors and leadership team are 100% volunteer, allowing us to operate with minimal administrative expenses. We also limit institutional overhead on our research grants to just 3%, meaning at least 97 cents of every research grant dollar is dedicated directly to scientific research.


Our focus is simple: Fund the best science, accelerate research, and bring meaningful treatments to patients as quickly as possible.

And we are putting those dollars to work.

 

BREAKTHROUGH SCIENCE: GETTING CLOSER TO TREATMENTS

Perhaps the most exciting development this year has been the progress in our exon-skipping research.


This technology is designed to help boys with rare genetic mutations, including Decker's, produce a functional version of the muscle-protecting protein their bodies are missing.


We are hearing and seeing incredibly encouraging results from related treatment approaches, including reports of boys experiencing meaningful improvements in muscle function. We are even hearing of patients whose physicians have been able to reduce or discontinue traditional steroid treatments.


Our goal is to help advance a treatment that could reach Decker and several other boys within the next 6–12 months, potentially sooner, depending on research, clinical readiness, and regulatory approvals.

Nothing is guaranteed, but for families who have spent years hearing what cannot be done, the progress is extraordinary.


At the same time, we committed $750,000 over three years to support Dr. John Lueck and his team at the University of Rochester in developing tRNA therapy. This technology is designed to overcome genetic stop signals that prevent the body from producing critical proteins. While our immediate focus is Duchenne, this platform could potentially benefit 3–4 million Americans affected by genetic diseases involving nonsense mutations. Think about that. Research inspired by one little boy could someday help millions.

 

DECKER'S JOURNEY: A PERSONAL UPDATE


Decker recently turned nine, and we are incredibly proud of him. After months of appointments, testing, and uncertainty, Decker was accepted into a clinical trial for an investigational drug developed by Satellos Bioscience. Unlike treatments focused on replacing dystrophin, this drug is being studied for its potential to help regenerate muscle.


Getting into the trial was anything but easy. One of the final requirements was an MRI that required Decker to lie perfectly still for nearly an hour. He failed his first two attempts because of movement. After the second attempt, he looked at me and said: "Daddy, I did the best I could do." As a father, those words are impossible to forget.


Before his third attempt, I found myself on my knees, praying and holding his toes, knowing how much this opportunity meant for his future.


He passed. Decker is now participating in the trial. It's far too early to know whether the treatment is working, but he is in the trial, and that alone was an enormous victory.

He continues to love drawing houses, building Legos, swimming, and spending time with his family. We are doing everything we can to protect his ability to keep doing the things he loves.


TAKING OUR FIGHT TO HARRISBURG AND WASHINGTON

Research alone isn't enough. We also need to improve the pathways that bring promising treatments to children. On September 30, we stood at the Pennsylvania State Capitol alongside Senator Scott Martin, Representative Nikki Rivera, and other elected officials to advocate for meaningful change. While our journey began with Decker, our fight is for every boy with Duchenne, especially those being left behind by today's treatments.


Our efforts include advocating for a Pennsylvania Duchenne Muscular Dystrophy Awareness Day, advancing newborn screening for Duchenne, and encouraging dedicated state research funding.


At the federal level, we have pushed for FDA reforms, faster approval pathways for platform technologies such as exon skipping, and stronger incentives for rare disease research. Our message is simple: When time is muscle, children cannot afford unnecessary delays.

 

AN INCREDIBLE YEAR OF COMMUNITY AND CONNECTIONS


Our supporters have made this an unforgettable year. Our first Golf Classic raised approximately $100,000, and generous friends hosted private dinners that helped introduce our mission to new supporters.


In October, we hosted a special Decker's Blueprint evening at Lincoln Financial Field in Philadelphia. Guests experienced the Eagles' locker room, field access, dinner in the Janney Tunnel Club, special guests, and an opportunity to hear directly from Dr. Lueck about the research we are funding.

 

Our #FlexForDecker Challenge has also opened remarkable doors. From President George W. Bush to Saquon Barkley, Jalen Brunson, Jason Kelce, Jalen Hurts, and Trea Turner, we have had incredible opportunities to meet people, share Decker's story, and spread awareness.


And our team continues to grow. We are excited to welcome Tracy Horst, Susan Eckert, Walt Legenstein, and Andrew Morgan to our Board of Directors, with Nicole Tyminski and Tom NyeSmith also helping lead our fundraising efforts.

 

WHAT COMES NEXT

We have accomplished a tremendous amount, but our work is far from finished.

We are focused on advancing exon-skipping therapies toward patients, accelerating Dr. Lueck's tRNA research, expanding our scientific and business partnerships, and continuing to advocate for changes that will help children receive treatments faster.


Our goal is to raise $5 million by December 31, 2028, to fund breakthrough research and accelerate promising treatments toward clinical use.


This coming Friday, November 20, we will be a part of Lancaster’s ExtraGive. Please come show your support from 5-9pm at South County Brewing!


SAVE THE DATE — APRIL 3, 2027!

Decker's Blueprint Dinner & Auction Gala will be Saturday, April 3, 2027Foundry 48 | Lititz, Pennsylvania

Please mark your calendars and join us for a special evening bringing together the people who have helped make this progress possible. We look forward to celebrating our accomplishments, strengthening relationships, and raising critical funding to accelerate the research ahead.

More details will be coming soon!

 

FROM OUR FAMILY TO YOURS — THANK YOU.

When Decker was diagnosed in January 2024, we were told what this disease would eventually take from him. We decided we weren't going to sit back and accept that future without a fight. There are days when this journey is exhausting. But then we meet another family, hear encouraging news from a scientist, or watch Decker sit at the kitchen table drawing the house he wants to build someday. And we remember exactly why we started.


We are not simply raising money. We are funding science that could change the future for Decker and thousands of other boys with Duchenne.


We are winning. Not because the battle is over, but because real progress is happening.

Thank you for believing in Decker, believing in the science, and standing beside our family.


We could not do this without you.


With gratitude and determination, Dan & Lauren Murphy

Time is muscle. The blueprint isn't finished until every boy has a path forward.


 
 
 

Comments


bottom of page